Cargando…
ROS Cocktails as an Adjuvant for Personalized Antitumor Vaccination?
Cancer is the second leading cause of death worldwide. Today, the critical role of the immune system in tumor control is undisputed. Checkpoint antibody immunotherapy augments existing antitumor T cell activity with durable clinical responses in many tumor entities. Despite the presence of tumor-ass...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161309/ https://www.ncbi.nlm.nih.gov/pubmed/34069708 http://dx.doi.org/10.3390/vaccines9050527 |